{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/20792"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/20792","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"Overexpression, purification and characterization of human proapolipoprotein A-I and mutants","abstract":"The cDNA coding the human proapoA-I was cloned into an Escherichia coli vector, overexpressed and purified to 99% homogeneity and characterized together with apoA-I purified from human plasma. SDS-PAGE, mass spectrometry and Edman sequence analysis showed that the initial Met residue is post translationally removed. The proapoA-I self associated, interacted with dimyristoyl phosphatidylcholine vesicles and formed secondary structures similar to the lipid-free apoA-I. Reconstituted HDL particles made with phospholipid and cholesterol by the Na-cholate method had identical particle sizes, distributions and contained the same number of apoproteins per particle when apoA-I or proapoA-I were used. Furthermore, their $\\alpha$-helical contents were the same, they had similar fluorescence properties and activated LCAT equally well. In conclusion, proapoA-I expressed and purified from E. coli is functionally and structurally indistinguishable from apoA-I purified from plasma when analyzed in vitro. Several proapoA-I mutants were constructed, purified and characterized. The deletion mutant proapoA-I$\\Delta$187-217, was purified and the molecular weight was determined by mass spectrometry to be 25462 Da. Cross-linking of the mutant showed that it primarily existed as a monomer, but could form dimers. The association with DMPC liposomes was significantly reduced, but the mutant protein was able to form rHDL particles by the Na-cholate method. These particles had smaller sizes, and a reduced $\\alpha$-helix content, but were equally stable to GdnHCl denaturation when compared to rHDL containing wild-type proapoA-I. The reactivity with LCAT was reduced by 5-fold.","abstract_html":"The cDNA coding the human proapoA-I was cloned into an Escherichia coli vector, overexpressed and purified to 99% homogeneity and characterized together with apoA-I purified from human plasma. SDS-PAGE, mass spectrometry and Edman sequence analysis showed that the initial Met residue is post translationally removed. The proapoA-I self associated, interacted with dimyristoyl phosphatidylcholine vesicles and formed secondary structures similar to the lipid-free apoA-I. Reconstituted HDL particles made with phospholipid and cholesterol by the Na-cholate method had identical particle sizes, distributions and contained the same number of apoproteins per particle when apoA-I or proapoA-I were used. Furthermore, their <span class=\"etd-inline-math\">&alpha;</span>-helical contents were the same, they had similar fluorescence properties and activated LCAT equally well. In conclusion, proapoA-I expressed and purified from E. coli is functionally and structurally indistinguishable from apoA-I purified from plasma when analyzed in vitro. Several proapoA-I mutants were constructed, purified and characterized. The deletion mutant proapoA-I$\\Delta$187-217, was purified and the molecular weight was determined by mass spectrometry to be 25462 Da. Cross-linking of the mutant showed that it primarily existed as a monomer, but could form dimers. The association with DMPC liposomes was significantly reduced, but the mutant protein was able to form rHDL particles by the Na-cholate method. These particles had smaller sizes, and a reduced <span class=\"etd-inline-math\">&alpha;</span>-helix content, but were equally stable to GdnHCl denaturation when compared to rHDL containing wild-type proapoA-I. The reactivity with LCAT was reduced by 5-fold.","abstract_has_math":true,"creators":["McGuire, Kirsten Arnvig"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":"Biochemistry","degree_department":null,"school":null,"contributors":["Jonas, Ana"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2011,"date_issued":"2011-05-07T12:49:25Z","date_published":"2011-05-07T12:49:25Z","updated_at":"2026-07-22T22:25:16Z","subjects":["Biology, Animal Physiology","Chemistry, Biochemistry"],"languages":["eng"],"rights":["Copyright 1996 McGuire, Kirsten Arnvig"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["9780591088762","AAI9702606","(UMI)AAI9702606"],"render_values":[{"text":"9780591088762","href":null,"code":true},{"text":"AAI9702606","href":null,"code":true},{"text":"(UMI)AAI9702606","href":null,"code":true}]}]},"links":{"outbound_url":"http://hdl.handle.net/2142/20792","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Jonas, Ana"]},{"key":"dc:creator","label":"Author","values":["McGuire, Kirsten Arnvig"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2011-05-07T12:49:25Z","10000-01-01","1996"]},{"key":"dc:type","label":"Dc Type","values":["text"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biochemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Biology, Animal Physiology","Chemistry, Biochemistry"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright 1996 McGuire, Kirsten Arnvig"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["9780591088762","AAI9702606","(UMI)AAI9702606","http://hdl.handle.net/2142/20792"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["The cDNA coding the human proapoA-I was cloned into an Escherichia coli vector, overexpressed and purified to 99% homogeneity and characterized together with apoA-I purified from human plasma. SDS-PAGE, mass spectrometry and Edman sequence analysis showed that the initial Met residue is post translationally removed. The proapoA-I self associated, interacted with dimyristoyl phosphatidylcholine vesicles and formed secondary structures similar to the lipid-free apoA-I. Reconstituted HDL particles made with phospholipid and cholesterol by the Na-cholate method had identical particle sizes, distributions and contained the same number of apoproteins per particle when apoA-I or proapoA-I were used. Furthermore, their $\\alpha$-helical contents were the same, they had similar fluorescence properties and activated LCAT equally well. In conclusion, proapoA-I expressed and purified from E. coli is functionally and structurally indistinguishable from apoA-I purified from plasma when analyzed in vitro. Several proapoA-I mutants were constructed, purified and characterized. The deletion mutant proapoA-I$\\Delta$187-217, was purified and the molecular weight was determined by mass spectrometry to be 25462 Da. Cross-linking of the mutant showed that it primarily existed as a monomer, but could form dimers. The association with DMPC liposomes was significantly reduced, but the mutant protein was able to form rHDL particles by the Na-cholate method. These particles had smaller sizes, and a reduced $\\alpha$-helix content, but were equally stable to GdnHCl denaturation when compared to rHDL containing wild-type proapoA-I. The reactivity with LCAT was reduced by 5-fold.","Two proapoA-I point mutants proapoA-ID9C and proapoA-IW-3:8:50:72F, were purified and the molecular weight determined, to 28866 Da and 28727 Da, respectively, in agreement with the calculated molecular weight without the initial Met residues residue. The proapoA-ID9C mutant protein was able to form rHDL particles by the Na-Cholate method, these particles were used to determine size and shape of the rHDL particles by atomic force microscopy.","Made available in DSpace on 2011-05-07T12:49:25Z (GMT). No. of bitstreams: 2 license.txt: 4922 bytes, checksum: 910b249b4beec47e7ab768910c8f966f (MD5) 9702606.pdf: 7434770 bytes, checksum: a1fb074eee05edae5d9654626cd12da5 (MD5) Previous issue date: 1996","Item marked as restricted to the 'UIUC Users [automated]' Group (id=2) by Howard Ding (hding2@illinois.edu) on 2011-05-07T14:46:18Z Item is restricted indefinitely.","Restriction data tranferred 2014-07-01T11:20:42-05:00 Original Data Group with Access UIUC Users [automated] Release Date: none Reason: ETDs are only available to UIUC Users without author permission","ETDs are only available to UIUC Users without author permission","U of I Only"]},{"key":"dc:title","label":"Title","values":["Overexpression, purification and characterization of human proapolipoprotein A-I and mutants"]}]}],"canonical_facts":{"dc:contributor":["Jonas, Ana"],"dc:creator":["McGuire, Kirsten Arnvig"],"dc:date":["2011-05-07T12:49:25Z","10000-01-01","1996"],"dc:description":["The cDNA coding the human proapoA-I was cloned into an Escherichia coli vector, overexpressed and purified to 99% homogeneity and characterized together with apoA-I purified from human plasma. SDS-PAGE, mass spectrometry and Edman sequence analysis showed that the initial Met residue is post translationally removed. The proapoA-I self associated, interacted with dimyristoyl phosphatidylcholine vesicles and formed secondary structures similar to the lipid-free apoA-I. Reconstituted HDL particles made with phospholipid and cholesterol by the Na-cholate method had identical particle sizes, distributions and contained the same number of apoproteins per particle when apoA-I or proapoA-I were used. Furthermore, their $\\alpha$-helical contents were the same, they had similar fluorescence properties and activated LCAT equally well. In conclusion, proapoA-I expressed and purified from E. coli is functionally and structurally indistinguishable from apoA-I purified from plasma when analyzed in vitro. Several proapoA-I mutants were constructed, purified and characterized. The deletion mutant proapoA-I$\\Delta$187-217, was purified and the molecular weight was determined by mass spectrometry to be 25462 Da. Cross-linking of the mutant showed that it primarily existed as a monomer, but could form dimers. The association with DMPC liposomes was significantly reduced, but the mutant protein was able to form rHDL particles by the Na-cholate method. These particles had smaller sizes, and a reduced $\\alpha$-helix content, but were equally stable to GdnHCl denaturation when compared to rHDL containing wild-type proapoA-I. The reactivity with LCAT was reduced by 5-fold.","Two proapoA-I point mutants proapoA-ID9C and proapoA-IW-3:8:50:72F, were purified and the molecular weight determined, to 28866 Da and 28727 Da, respectively, in agreement with the calculated molecular weight without the initial Met residues residue. The proapoA-ID9C mutant protein was able to form rHDL particles by the Na-Cholate method, these particles were used to determine size and shape of the rHDL particles by atomic force microscopy.","Made available in DSpace on 2011-05-07T12:49:25Z (GMT). No. of bitstreams: 2 license.txt: 4922 bytes, checksum: 910b249b4beec47e7ab768910c8f966f (MD5) 9702606.pdf: 7434770 bytes, checksum: a1fb074eee05edae5d9654626cd12da5 (MD5) Previous issue date: 1996","Item marked as restricted to the 'UIUC Users [automated]' Group (id=2) by Howard Ding (hding2@illinois.edu) on 2011-05-07T14:46:18Z Item is restricted indefinitely.","Restriction data tranferred 2014-07-01T11:20:42-05:00 Original Data Group with Access UIUC Users [automated] Release Date: none Reason: ETDs are only available to UIUC Users without author permission","ETDs are only available to UIUC Users without author permission","U of I Only"],"dc:identifier":["9780591088762","AAI9702606","(UMI)AAI9702606","http://hdl.handle.net/2142/20792"],"dc:language":["eng"],"dc:rights":["Copyright 1996 McGuire, Kirsten Arnvig"],"dc:subject":["Biology, Animal Physiology","Chemistry, Biochemistry"],"dc:title":["Overexpression, purification and characterization of human proapolipoprotein A-I and mutants"],"dc:type":["text"],"thesis:degree_discipline":["Biochemistry"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:25:16Z"}